Company

Sable Bio

Biotechnology Research London, City of, United Kingdom 13 employees

Employees: 13
Contacts: 2
Emails: 2

www.sablebio.com LinkedIn Crunchbase

Sable Bio Overview

Headquarters: London, City of, United Kingdom
Website: www.sablebio.com
Industry: Biotechnology Research
Employees: 13
Founded: 2023
Funding: 1.9M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

in gene expression analysis across toxicology-relevant organisms to help enhance their already excellent product. The synergy between our specialised bioinformatics capabilities and their groundbreaking platform has created opportunities for meaningful impact in drug development.

About Sable Bio

Prevent target safety failures with unique data insights and cutting-edge approaches. Better prediction of drug safety could help patients and prevent hugely costly trial failures. Our advanced workflows assess clinical side effects and predict potential risks for drugs in development using a suite of data modalities. Empower your drug development process with our state-of-the-art solutions. Build trust with industry-leading validation across several proof points. Gain deeper insights into target safety, minimize risks, and optimize assay validation strategies.

Sable Bio Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage

Sable Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Rob Greenwood	CEO, Investor, Ned, Advisor		View
Amanda Giddings	VP Head of Project Toxicology	Bishop's Stortford, England, United Kingdom	Email
Justin Stebbing	Editor-in-chief of Oncogene, Professor	London, England, United Kingdom	Email